Medical diagnostics company Hologic has entered into a definitive agreement to be acquired by private equity firms Blackstone and TPG in a transaction valued at up to $18.3 billion (official press release). The deal represents one of the largest healthcare take-private transactions announced in 2025.

SEE ALSO
• Roshel to Produce Canada’s First Ballistic Steel in Ontario
• Airbus Opens Helicopter Distribution Centre in Niagara Falls
• Siemens to establish R&D centre in Oakville, creating up to 90 jobs
• Trump Tariffs Canada: Layoffs, Severance, and Employee Rights

Details

Under the terms of the agreement, Blackstone and TPG will acquire all outstanding shares of Hologic at $76 per share in cash.

• Shareholders will also receive a non-tradable contingent value right worth up to an additional $3 per share, based on revenue performance targets for Hologic’s breast health division in fiscal years 2026 and 2027.
• Including the contingent consideration, the total potential value of the deal reaches $79 per share.

The transaction is expected to close in the first half of 2026, subject to customary closing conditions and regulatory approvals.

Company Background

Hologic is a Massachusetts-based medical technology company focused on women’s health diagnostics, including breast and cervical cancer screening technologies.

• The company has faced declining demand following the COVID-19 pandemic and has seen increased competition in its core segments.
• This acquisition follows a period...

Read Full Story: https://news.google.com/rss/articles/CBMioAFBVV95cUxNdlh5MjlNOHpMZkQwazU4T3Jx...